Christophe Rey

1.6k total citations
27 papers, 607 citations indexed

About

Christophe Rey is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christophe Rey has authored 27 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christophe Rey's work include Cancer Immunotherapy and Biomarkers (6 papers), Cancer Research and Treatments (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). Christophe Rey is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Cancer Research and Treatments (3 papers) and Sarcoma Diagnosis and Treatment (3 papers). Christophe Rey collaborates with scholars based in France, Spain and United States. Christophe Rey's co-authors include Alban Bessede, Antoîne Italiano, Isabelle Soubeyran, François Le Loarer, Benjamin Buaud, Agnès Aubert, Carole Vaysse, Agnès Nadjar, Véronique Pallet and Sophie Layé and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Analytical Chemistry.

In The Last Decade

Christophe Rey

25 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christophe Rey France 13 229 209 144 101 87 27 607
Christian Fork Germany 16 347 1.5× 131 0.6× 183 1.3× 50 0.5× 93 1.1× 21 782
Usha Rai United States 5 270 1.2× 162 0.8× 153 1.1× 33 0.3× 67 0.8× 5 571
Eslam E. Abd El-Fattah Egypt 14 256 1.1× 91 0.4× 97 0.7× 58 0.6× 72 0.8× 18 496
Suyu Chen China 12 171 0.7× 146 0.7× 69 0.5× 84 0.8× 70 0.8× 35 512
Kei Goto Japan 17 231 1.0× 98 0.5× 47 0.3× 51 0.5× 121 1.4× 57 622
Eduardo Mascareno United States 16 405 1.8× 203 1.0× 105 0.7× 30 0.3× 74 0.9× 28 765
Shuyu Gui China 17 345 1.5× 78 0.4× 123 0.9× 65 0.6× 116 1.3× 38 649
Atsuko Wakikawa Japan 8 231 1.0× 66 0.3× 143 1.0× 27 0.3× 78 0.9× 8 538
Daniel A. Richards United States 14 342 1.5× 75 0.4× 90 0.6× 59 0.6× 99 1.1× 21 773
Li‐Hao Huang United States 13 229 1.0× 201 1.0× 110 0.8× 27 0.3× 84 1.0× 18 676

Countries citing papers authored by Christophe Rey

Since Specialization
Citations

This map shows the geographic impact of Christophe Rey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Rey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Rey more than expected).

Fields of papers citing papers by Christophe Rey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Rey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Rey. The network helps show where Christophe Rey may publish in the future.

Co-authorship network of co-authors of Christophe Rey

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Rey. A scholar is included among the top collaborators of Christophe Rey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Rey. Christophe Rey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toulmonde, Maud, Mariella Spalato Ceruso, Thibaud Valentin, et al.. (2025). Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumab. Signal Transduction and Targeted Therapy. 10(1). 202–202. 2 indexed citations
2.
Vanhersecke, Lucile, Antoine Bougoüin, Amandine Crombé, et al.. (2023). Standardized Pathology Screening of Mature Tertiary Lymphoid Structures in Cancers. Laboratory Investigation. 103(5). 100063–100063. 49 indexed citations
3.
Bessede, Alban, Aurélien Marabelle, Jean‐Philippe Guégan, et al.. (2022). Impact of acetaminophen on the efficacy of immunotherapy in cancer patients. Annals of Oncology. 33(9). 909–915. 28 indexed citations
4.
Cousin, Sophie, Coralie Cantarel, Jean‐Philippe Guégan, et al.. (2022). Regorafenib–avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial. European Journal of Cancer. 162. 161–169. 35 indexed citations
5.
Nafia, Imane, Maud Toulmonde, Christophe Rey, et al.. (2020). IDO Targeting in Sarcoma: Biological and Clinical Implications. Frontiers in Immunology. 11. 274–274. 25 indexed citations
6.
Laroche‐Clary, Audrey, Carlo Lucchesi, Christophe Rey, et al.. (2018). CHK1 inhibition in soft-tissue sarcomas: biological and clinical implications. Annals of Oncology. 29(4). 1023–1029. 14 indexed citations
7.
Chaire, Vanessa, et al.. (2017). Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas. Journal of Hematology & Oncology. 10(1). 84–84. 23 indexed citations
8.
Rey, Christophe, Agnès Nadjar, Benjamin Buaud, et al.. (2015). Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro. Brain Behavior and Immunity. 55. 249–259. 120 indexed citations
9.
Rey, Christophe, Benjamin Faustin, Rosamaria Ruggieri, et al.. (2015). The MAP3K ZAK, a novel modulator of ERK-dependent migration, is upregulated in colorectal cancer. Oncogene. 35(24). 3190–3200. 27 indexed citations
10.
Rey, Christophe, Isabelle Soubeyran, Alban Bessede, et al.. (2013). HIPK1 drives p53 activation to limit colorectal cancer cell growth. Cell Cycle. 12(12). 1879–1891. 28 indexed citations
11.
Rey, Christophe, et al.. (2012). Non-Antioxidant Properties of α-Tocopherol Reduce the Anticancer Activity of Several Protein Kinase Inhibitors In Vitro. PLoS ONE. 7(5). e36811–e36811. 24 indexed citations
12.
Gissot, Arnaud, et al.. (2012). Synthesis and evaluation of apoptosis induction of thienopyrimidine compounds on KRAS and BRAF mutated colorectal cancer cell lines. Bioorganic & Medicinal Chemistry. 20(22). 6724–6731. 12 indexed citations
13.
Soubeyran, Isabelle, Thierry Lesté-Lasserre, Guillaume Drutel, et al.. (2011). Tissue Microarray Cytometry Reveals Positive Impact of Homeodomain Interacting Protein Kinase 2 in Colon Cancer Survival Irrespective of p53 Function. American Journal Of Pathology. 178(5). 1986–1998. 13 indexed citations
14.
Haurie, Valérie, Hélène Dumay‐Odelot, Daniel Da Silva, et al.. (2010). Two isoforms of human RNA polymerase III with specific functions in cell growth and transformation. Proceedings of the National Academy of Sciences. 107(9). 4176–4181. 59 indexed citations
15.
Albucher, Jean François, P. Chaine, Jean‐Louis Mas, et al.. (2007). [Consensus about indications of endovascular closure of the patent foramen ovale after an ischemic brain stroke].. PubMed. 100(9). 771–4. 2 indexed citations
16.
Rey, Christophe, et al.. (2006). Pileflebitis idiopática en paciente con mutación del factor V Leiden. Anales de Medicina Interna. 23(7). 2 indexed citations
17.
Franco, J. Campos, Christophe Rey, E. Becerra, & Arturo González‐Quintela. (2002). Fallo hepático fulminante asociado al uso de cocaína. Anales de Medicina Interna. 19(7). 365–7. 7 indexed citations
18.
19.
20.
Housset, Chantal, Elisabeth Lasnier, Christophe Rey, et al.. (1999). Direct cytotoxicity of hypoxia‐reoxygenation towards sinusoidal endothelial cells in the rat. Liver International. 19(1). 42–49. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Fork Breakdown of academic impact, for papers by Usha Rai Breakdown of academic impact, for papers by Eslam E. Abd El-Fattah Breakdown of academic impact, for papers by Suyu Chen Breakdown of academic impact, for papers by Kei Goto Breakdown of academic impact, for papers by Eduardo Mascareno Breakdown of academic impact, for papers by Shuyu Gui Breakdown of academic impact, for papers by Atsuko Wakikawa Breakdown of academic impact, for papers by Daniel A. Richards Breakdown of academic impact, for papers by Li‐Hao Huang
Rankless by CCL
2026